Bank of New York Mellon
PRVL

Bank of New York Mellon’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bank of New York Mellon’s Portfolio PRVL Stock Details PRVL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$773K Sell
2020
Q3 		$1.32M Sell
2020
Q2 		$2.94M Sell
2020
Q1 		$2.75M Buy
2019
Q4 		$3.38M Buy
2019
Q3 		$2.58M Buy